| CAT No: | CL-DXRN-35 |
| CAS No: | NA |
| Mol.F: | C2613CH26D3NO11 : C2HF3O2 |
| Mol.Wt.: | 547.5 : 114.0 |
| Rel. Cas No: | |
| Chemical Name: | (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to Doxorubicin 13CD3 TFA is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Doxorubicin 13CD3 TFA is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetateCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Doxorubicin Molecular Formula: C2613CH26D3NO11 : C2HF3O2
Molecular Weight: 547.5 : 114.0
Storage: Store in a cool, dry place.
| Product Name: | Doxorubicin 13CD3 TFA |
| CAS No: | |
| Mol.F.: | C2613CH26D3NO11 : C2HF3O2 |
| Mol.Wt.: | 547.5 : 114.0 |
 (TFA Salt).jpg)
.jpg)
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: